MedTrace Logo

Chances for Success of CavatermTM Surgery as a Function of Uterus Probe Length

NCT01436903 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 290

Last updated 2013-03-08

No results posted yet for this study

Summary

CavatermTM is a second-generation thermal balloon ablation device in the management of menorrhagia. The purpose of this study is to investigate the success (questionnaire) of CavatermTM dependent on uterus probe length, especially corpus probe length, which is measured during surgery.

Conditions

  • Menorrhagia

Interventions

DEVICE

Thermal Balloon Endometrial Ablation

Thermal Balloon Endometrial Ablation for 10 minutes after curettage

Sponsors & Collaborators

  • Medical University of Vienna

    lead OTHER

Principal Investigators

  • Beda W. Hartmann, Univ.-Doz. · Medical University of Vienna

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
30 Years
Max Age
55 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-09-30
Primary Completion
2011-04-30
Completion
2011-04-30

Countries

  • Austria

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01436903 on ClinicalTrials.gov